Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 7 matching records.
7 results — page 1 of 1
- Level DLaboratory StudyPubMed
Discovery of a selective dual-specificity tyrosine phosphorylation-regulated kinase 1B inhibitor with anti-adipogenic and anti-diabetic activities.
Laboratory Study on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol - Level DLaboratory StudyEurope PMC
Genome-wide prioritization reveals novel gene signatures associated with cardiotoxic effects of tyrosine kinase inhibitors
Laboratory Study on Cardiovascular Disease, published in Oncol Lett (2021) — summary generated from the PubMed abstract.
- 2021
Oncol Lett7 citations - Level DLaboratory StudyPubMed
Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer.
Laboratory Study, published in Pharmaceutics (2021) — summary generated from the PubMed abstract.
- 2021
Pharmaceutics22 citations - Level BClinical TrialEurope PMC
Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials
Clinical Trial, published in Front Oncol (2021) — summary generated from the PubMed abstract.
- 2021
Front Oncol54 citations - Level DLaboratory StudyEurope PMC
Latest progress in tyrosine kinase inhibitors
Laboratory Study, published in Oncotarget (2014) — summary generated from the PubMed abstract.
- 2014
Oncotarget1 citations - Level DLaboratory StudyPubMed
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells.
Laboratory Study, published in PLoS One (2011) — summary generated from the PubMed abstract.
- 2011
PLoS One - Level DAnimal StudyEurope PMC
EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice
Animal Study on Type 2 Diabetes, published in Diabetes (2009) — summary generated from the PubMed abstract.
- 2009
Diabetes51 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406